Financhill
Back

AtriCure Quote, Financials, Valuation and Earnings

AtriCure Price Quote

$30.74
+0.01 (+2.3%)
(Updated: December 21, 2024 at 5:15 AM ET)

AtriCure Key Stats

Sell
33
AtriCure (ATRC) is a Sell

Day range:
$29.56 - $31.02
52-week range:
$18.94 - $39.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.21
P/B ratio:
3.22%

Volume:
666.5K
Avg. volume:
420.1K
1-year change:
-10.88%
Market cap:
$1.5B
Revenue:
$399.2M
EPS:
$-0.83

How Much Does AtriCure Make?

Data Unavailable

Is AtriCure Growing As A Company?

Data Unavailable

AtriCure Stock Price Performance

  • Did AtriCure Stock Go Up Last Month?
    AtriCure share price went down by -14.71% last month
  • Did ATRC's Share Price Rise Over The Last Year?
    ATRC share price fell by -10.88% over the past 1 year

What Is AtriCure 52-Week High & Low?

  • What Is AtriCure’s 52-Week High Share Price?
    AtriCure has traded as high as $39.05 over the past 52 weeks
  • What Is AtriCure’s 52-Week Low Share Price?
    AtriCure has traded as low as $18.94 over the past 52 weeks

AtriCure Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy AtriCure?

Data Unavailable

Is AtriCure Cash Flow Positive?

Data Unavailable

AtriCure Return On Invested Capital

Data Unavailable

AtriCure Earnings Date & Stock Price

  • What Is AtriCure's Stock Price Today?
    A single share of ATRC can be purchased today for 30.73
  • What Is AtriCure’s Stock Symbol?
    AtriCure trades on the nasdaq under the ticker symbol: ATRC
  • When Is AtriCure’s Next Earnings Date?
    The next quarterly earnings date for AtriCure is scheduled on February 14, 2025
  • When Is ATRC's next ex-dividend date?
    AtriCure's next ex-dividend date is December 21, 2024
  • How To Buy AtriCure Stock?
    You can buy AtriCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

AtriCure Competitors

  • Who Are AtriCure's Competitors?
    Below is a list of companies who compete with AtriCure or are related in some way:
    • Boston Scientific Corp (BSX)
    • Perspective Therapeutics Inc (CATX)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

AtriCure Dividend Yield

Data Unavailable

AtriCure Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 13.44%
Revenue: 17.93% 3.26%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 45.11
Upside from Last Price: 46.8%

Major Shareholders

Data Unavailable